Landscapes / Companies

Suzhou Zelgen Biopharmaceuticals Co.,Ltd not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
2 in Phase 2
Next date
ZG005, Phase 1/2 trial completes
Drugs
4
in active trials · 17 in all
Trials
21 active
78 since 2021

Drugs4

DrugHow it worksPartnerStageNext dateDetails
—
Phase 3 Apr 2027Phase 1/2 trial completes
—
Phase 3 Apr 2027Phase 1/2 trial completes
Janus kinase inhibitor
Phase 1/2 Apr 2027Phase 1/2 trial completes
—
Phase 1/2 May 2027Phase 1/2 trial completes

About

No active trial
13 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Following is part of Solo: you see every change to Suzhou Zelgen Biopharmaceuticals Co.,Ltd the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in